1 / 12

Effect of Diabetes Mellitus on Sepsis Induced Multiple Organ Dysfunction Syndrome

Effect of Diabetes Mellitus on Sepsis Induced Multiple Organ Dysfunction Syndrome. By Hayes Brown. Need. Each year 500,000 people develop sepsis, with a survival rate of 29 percent Millions are spent on patient safety research 250,000 die each year in the United states. Knowledge Base.

willow-weiss
Télécharger la présentation

Effect of Diabetes Mellitus on Sepsis Induced Multiple Organ Dysfunction Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Effect of Diabetes Mellitus on Sepsis Induced Multiple Organ Dysfunction Syndrome By Hayes Brown

  2. Need • Each year 500,000 people develop sepsis, with a survival rate of 29 percent • Millions are spent on patient safety research • 250,000 die each year in the United states

  3. Knowledge Base

  4. Cytokine

  5. Death in women from diabetes Diabetes Mellitus

  6. Type 1 and Type 2

  7. DM and Sepsis

  8. Knowledge Base • Studies could help determine the relationship of DM and reduced risk of ALI

  9. Suggested Reasons • Hospitalized Earlier • Red blood cell deformability increases risk of renal failure • Diabetics more vulnerable to bacteremia

  10. Literature Review • Dr Tomsen (2008)-heightened risk of infections in diabetic people • Dr. Reimar(2007)-patients with bacteremia caused by E. coli and related bacteria found about 17 percent had diabetes, compared with 6% without diabetes • Dr. Friedman(2005)- DM patients have a greater risk of renal failure due to red blood cell deformibility

  11. Literature Review • Dr. Annette Esper (2006)-patients with Diabetes Mellitus less likely to develop respiratory failure during periods of sepsis, but more likely to develop infection of the urinary system • Dr. Martin- those with (2006) DM less likely to develop respiratory infection because DM patients may be hospitalized earlier

  12. Bibliography • ^ Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001-03-08). "Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis • Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (Apr 2003). "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference • Meduri GU, Golden E, Freire AX, et al (Apr 2007). "Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial • http://www.nlm.nih.gov/medlineplus/ency/article/000666.htm • http://my.clevelandclinic.org/disorders/sepsis/hic_sepsis.aspx • Cannon JG (2000). "Inflammatory Cytokines in Nonpathological States". News Physiol Sci. 15: 298-303 • Kabay B, Kocaefe C, Baykal A, et al. (2007). "Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis". World J Surg 31 • Janeway CA, et al., ed (2005). Immunobiology. The immune system in Health and Disease (6th ed.). New York: Taylor & Francis Group; Garland Science • Lucas AD, Greaves DR (November 2001). "Atherosclerosis: role of chemokines and macrophages". Expert Rev Mol Med 3 (25): 1–18. • Dellinger RP, Levy MM, Carlet JM, et al., for the International Surviving Sepsis Campaign Guidelines Committee. (2008). • McKenna M (December 2008). "Controversy swirls around early goal-directed therapy in sepsis: pioneer defends ground- breaking approach to deadly disease". Ann Emerg Med52 (6): 651–4 • Carr R, Brocklehurst P, Doré CJ, Modi N (January 2009). "Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial"

More Related